From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

The obsession of the housing market and the reality for shareholders in Barratt Developments

By Chris Bailey | Wednesday 8 February 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


As the CEO of Barratt Developments (BDEV) observed during the conference call earlier today, the company’s half year numbers showed a “very strong operational performance”. Compared to a year ago, total home completions rose by 6.9%, adjusted profits were up by 15.9%, return on capital employed was up to 29.6% and, whilst net cash fell just over 14%, it was still just shy of £970 million. Happy days then for a leading housebuilder with a market cap of just over £4.6 billion today? So why are the shares, which are up about 1% today as I write, down by more than 25% during the last year? Is it something to do with the “difficult housing market” also talked about?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 06:28:44